Sabturani, Ruhaida A.

HRN: 22-86-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2023
CEFTRIAXONE 1G (VIAL)
04/12/2023
04/18/2023
IV
430mg
OD
PCAP Severe
Waiting Final Action 
04/12/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
04/12/2023
04/18/2023
IV
22mg
Q24h
PCAP Severe
Waiting Final Action 
04/13/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
04/13/2023
04/19/2023
ORAL
1 Ml
OD
PCAP SEVERE
Waiting Final Action 
04/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/13/2023
04/19/2023
IV DRIP
215 Mg
Q6
Pcap C
Waiting Final Action 
04/13/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/13/2023
04/19/2023
IVT
65 Mg
OD
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: